RU2017146642A - Вспомогательный плазмидный лентивирусный экспрессионный вектор для получения высоких титров vpx-содержащих лентивирусных частиц, обеспечивающий эффективное заражение моноцитов и дендритных клеток человека - Google Patents
Вспомогательный плазмидный лентивирусный экспрессионный вектор для получения высоких титров vpx-содержащих лентивирусных частиц, обеспечивающий эффективное заражение моноцитов и дендритных клеток человека Download PDFInfo
- Publication number
- RU2017146642A RU2017146642A RU2017146642A RU2017146642A RU2017146642A RU 2017146642 A RU2017146642 A RU 2017146642A RU 2017146642 A RU2017146642 A RU 2017146642A RU 2017146642 A RU2017146642 A RU 2017146642A RU 2017146642 A RU2017146642 A RU 2017146642A
- Authority
- RU
- Russia
- Prior art keywords
- vpx
- expression vector
- obtaining high
- lentivirus
- depatic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
- C12N15/867—Retroviral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Virology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Cell Biology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Claims (1)
- Вспомогательный плазмидный лентивирусный экспрессионный вектор для получения высоких титров Vpx-содержащих вирусных частиц, обеспечивающий эффективное заражение моноцитов и дендритных клеток человека, кодирующий последовательность гена Vpx, включающий в качестве базовых элементов, обеспечивающих функционирование вектора последовательность вирион-ассоциированного белка Vpx, содержащую С-концевой HIV-1 gag/pol мотив и FLAG последовательность, и объединенную с последовательностью гена трансактиваторного белка Rev через специфическую последовательность Т2А, обеспечивающую расщепление слитых белков во время процесса трансляции мРНК трансгена; в качестве регуляторных элементов - RSV промотор/ энхансер (rous sarcoma virus) и NES (nuclear export signal) - сигнал экспорта из ядра в цитоплазму.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2017146642A RU2697781C2 (ru) | 2017-12-28 | 2017-12-28 | Вспомогательный плазмидный лентивирусный экспрессионный вектор для получения высоких титров vpx-содержащих лентивирусных частиц, обеспечивающий эффективное заражение моноцитов и дендритных клеток человека |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2017146642A RU2697781C2 (ru) | 2017-12-28 | 2017-12-28 | Вспомогательный плазмидный лентивирусный экспрессионный вектор для получения высоких титров vpx-содержащих лентивирусных частиц, обеспечивающий эффективное заражение моноцитов и дендритных клеток человека |
Publications (3)
Publication Number | Publication Date |
---|---|
RU2017146642A true RU2017146642A (ru) | 2019-06-28 |
RU2017146642A3 RU2017146642A3 (ru) | 2019-07-17 |
RU2697781C2 RU2697781C2 (ru) | 2019-08-19 |
Family
ID=67209747
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2017146642A RU2697781C2 (ru) | 2017-12-28 | 2017-12-28 | Вспомогательный плазмидный лентивирусный экспрессионный вектор для получения высоких титров vpx-содержащих лентивирусных частиц, обеспечивающий эффективное заражение моноцитов и дендритных клеток человека |
Country Status (1)
Country | Link |
---|---|
RU (1) | RU2697781C2 (ru) |
-
2017
- 2017-12-28 RU RU2017146642A patent/RU2697781C2/ru active
Also Published As
Publication number | Publication date |
---|---|
RU2697781C2 (ru) | 2019-08-19 |
RU2017146642A3 (ru) | 2019-07-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Merten et al. | Large-scale manufacture and characterization of a lentiviral vector produced for clinical ex vivo gene therapy application | |
Bobadilla et al. | Efficient transduction of myeloid cells by an HIV-1-derived lentiviral vector that packages the Vpx accessory protein | |
Apolonia et al. | Promiscuous RNA binding ensures effective encapsidation of APOBEC3 proteins by HIV-1 | |
Negre et al. | Characterization of novel safe lentiviral vectors derived from simian immunodeficiency virus (SIVmac251) that efficiently transduce mature human dendritic cells | |
Behrens et al. | Nuclear export signal masking regulates HIV-1 rev trafficking and viral RNA nuclear export | |
Torresilla et al. | Detection of the HIV-1 minus-strand-encoded antisense protein and its association with autophagy | |
Hanke et al. | HERV‐K (HML‐2), a seemingly silent subtenant–but still waters run deep | |
Brinzevich et al. | HIV-1 interacts with human endogenous retrovirus K (HML-2) envelopes derived from human primary lymphocytes | |
AU2018336042B2 (en) | Retroviral vectors | |
Grewe et al. | Cytoplasmic utilization of human immunodeficiency virus type 1 genomic RNA is not dependent on a nuclear interaction with gag | |
Barbeau et al. | Does chronic infection in retroviruses have a sense? | |
Chen et al. | Cytoplasmic tail truncation of SARS-CoV-2 spike protein enhances titer of pseudotyped vectors but masks the effect of the D614G mutation | |
CN116157116A (zh) | 用于产生病毒融合体的方法和组合物 | |
Sakkhachornphop et al. | Zinc finger protein designed to target 2-long terminal repeat junctions interferes with human immunodeficiency virus integration | |
WO2009087110A1 (en) | Secretable hiv entry inhibitory peptides for therapy of hiv infection | |
EP2583974A1 (en) | Pseudotyping of foamy viruses | |
Ratner | A role for an HTLV-1 vaccine? | |
Rawson et al. | Transcription start site heterogeneity and preferential packaging of specific full-length RNA species are conserved features of primate lentiviruses | |
Kramer et al. | The human endogenous retrovirus K (HML-2) has a broad envelope-mediated cellular tropism and is prone to inhibition at a post-entry, pre-integration step | |
Schüle et al. | Restriction of HIV-1 replication in monocytes is abolished by Vpx of SIVsmmPBj | |
Hatziioannou et al. | Matrix-induced inhibition of membrane binding contributes to human immunodeficiency virus type 1 particle assembly defects in murine cells | |
US20180127470A1 (en) | Cell Lines | |
Pérot et al. | From viruses to genes: syncytins | |
Wolfrum et al. | Impact of viral accessory proteins of SIVsmmPBj on early steps of infection of quiescent cells | |
RU2017146642A (ru) | Вспомогательный плазмидный лентивирусный экспрессионный вектор для получения высоких титров vpx-содержащих лентивирусных частиц, обеспечивающий эффективное заражение моноцитов и дендритных клеток человека |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
QB4A | Licence on use of patent |
Free format text: LICENCE FORMERLY AGREED ON 20210628 Effective date: 20210628 |